Another study revealed that ALOXE3 is markedly downregulated in human glioblastoma (GBM) and that ALOXE3 deficiency renders GBM cells resistant to ferroptosis, promoting GBM cell survival (Yang et al., 2021). Here, ALOXE3 is linked to glioblastoma.